UCB is a Belgian manufacturer of biopharmaceutical products. The company is engaged in the provision of therapy for central nervous system disorders, inflammatory and oncology disorders. UCB head office is located in Brussels.
They have consistently paid a level or increasing dividend for over 5 years, although this is projected to dip slightly before resuming its upward trajectory.
- Pharmaceuticals & Biotechnology
- 🇧🇪 Belgium
- €78.80 Friday's close
52 Week High3.09%26 April 2018
52 Week Low0.0%13 September 2018
Next Ex-Div-Date Countdown
|Ex-Div Date||Pay Date||Year||Type||Frequency||Status||Amount|
|26 Apr 2010||29 Apr 2010||2009||Final||Semiannually||Paid||96¢|
|02 May 2011||05 May 2011||2010||Final||Annually||Paid||98¢|
|27 Apr 2012||03 May 2012||2011||Final||Annually||Paid||100¢|
|02 May 2013||07 May 2013||2012||Final||Annually||Paid||102¢|
|29 Apr 2014||05 May 2014||2013||Final||Annually||Paid||104¢|
|04 May 2015||06 May 2015||2014||Final||Annually||Paid||106¢|
|29 Apr 2016||03 May 2016||2015||Final||Annually||Paid||110¢|
|28 Apr 2017||03 May 2017||2016||Final||Annually||Paid||115¢|
|27 Apr 2018||02 May 2018||2017||Final||Annually||Paid||118¢|
UCB optimized dividend - 12 month history
UCB share price - 12 month history
Try the real thing now:
You currently don't have access this feature, however you can preview the functionality.
This is a fully-functional demo intended to showcase the usefulness of this product using old data.
By proceeding you acknowledge that shown here is old data for demonstration purposes only.
To immediately activate your free account and see the live data you can log in with Facebook or LinkedIn: